Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 02, 2015 2:39 PM ET

Biotechnology

Company Overview of LifeCell Corporation

Company Overview

LifeCell Corporation develops and markets tissue repair products for reconstructive, orthopedic, and urogynecologic biosurgery markets. The company’s products include Strattice Reconstructive Tissue Matrix and AlloDerm Regenerative Tissue Matrix for plastic, reconstructive, general surgical, burn, and periodontal procedures; Cymetra Regenerative Tissue Matrix, a particulate form of AlloDerm Tissue Matrix suitable for injection; and Repliform Regenerative Tissue Matrix for urogynecologic surgical procedures. It also offers GraftJacket for orthopedic surgical procedures; AlloCraft DBM for bone grafting procedures; and REVOLVE System that offers fat transfer processing in a range of aesthetic a...

One Millennium Way

Branchburg, NJ 08876-3876

United States

Founded in 1986

443 Employees

Phone:

908-947-1100

Fax:

908-947-1089

Key Executives for LifeCell Corporation

Chief Executive Officer and President
Age: 57
Interim Chief Financial Officer
Chief Executive Officer of Kinetic Concepts Inc. and President of Kinetic Concepts Inc.
Age: 49
Senior Vice President of Development Regulatory Affairs & Quality
Age: 60
Principal Accounting Officer and Controller
Compensation as of Fiscal Year 2015.

LifeCell Corporation Key Developments

Lifecell Corporation Receives Jury Verdict from the United States District Court for the Eastern District of Virginia, Norfolk Division in a Patent Infringement Suit Filed by Lifenet Health

On November 18, 2014, LifeCell Corporation received a jury verdict from the United States District Court for the Eastern District of Virginia, Norfolk Division in a patent infringement suit filed by LifeNet Health against LifeCell in 2013. The jury found that LifeNet's U.S. Patent 6,569,200 was not invalid and was infringed by certain accused LifeCell regenerative tissue matrix products, and further awarded LifeNet a lump sum damages amount of $34.7 million. The company expects that LifeNet will seek pre-judgment interest on the damages amount. Any damages award that is maintained after appeal would be additionally subject to post-judgment interest. At this time the company is unable to estimate the range of damages related to pre- and post-judgment interest, or any further amounts LifeNet may seek in post-trial motions through costs, attorneys fees or otherwise. It is important to note that there will be no change in the supply or availability of LifeCell products as a result of this verdict, and LifeNet has not sought an injunction in the case.

KCI, Lifecell Corporation and Systagenix Wound Management, Limited Appoint Brian T. Busenlehner as Interim Chief Financial Officer

Effective October 29, 2014, Brian T. Busenlehner was appointed to the position of interim Chief Financial Officer for the company's operating subsidiaries, KCI, LifeCell Corporation and Systagenix Wound Management, Limited ('together with the Company, the Acelity Companies'). Since 2007, Mr. Busenlehner has served as Vice President, Corporate Controller of KCI and now the Acelity Companies.

Philip M. Croxford to Leave as President, Regenerative Medicine of LifeCell Corporation

LifeCell Corporation announced that effective September 24, 2014, Philip M. Croxford is leaving his position as President, Regenerative Medicine, to pursue other opportunities.

Similar Private Companies By Industry

Company Name Region
GTS Proteomics United States
MIICRO, Inc. United States
Genextropy, Inc. United States
Protea Biosciences, Inc. United States
Astralis Ltd. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
October 30, 2014
LifeCell Corporation, Marketing and Distribution Rights of SPY Elite System
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LifeCell Corporation, please visit www.lifecell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.